Revenue Growth Drivers

Reported five-year revenue, EPS, and FCF CAGR are unavailable, limiting evidence of durable compounding versus peers with clearer multi-year growth histories.

Negative TTM ROIC suggests current reinvestment is not yet translating into value-creating expansion, which weakens the case for sustained revenue compounding.

Low capex intensity at 13.1% of revenue supports some scalability, but it is not enough to offset the absence of proven growth acceleration.

Zero R&D intensity implies limited product-led reinvestment, so future growth likely depends more on execution than on structurally expanding innovation capacity.

Market Tailwinds

No segmentation concentration data is provided, so the company’s ability to scale through dominant share gains versus peers cannot be evidenced.

The negative cash conversion cycle improves working-capital efficiency, but it mainly supports liquidity rather than directly expanding long-term revenue capacity.

Valuation multiples suggest the market expects some growth, yet peer-relative tailwind strength cannot be confirmed without disclosed operating expansion metrics.

Compared with stronger compounders, the available data shows limited proof of structural demand acceleration or multi-year market expansion.

Scalability Expansion

Capex-to-revenue of 13.1% indicates a relatively asset-light model, which can aid scaling versus more capital-intensive peers.

Capex-to-operating-cash-flow of 62.0% shows meaningful reinvestment burden, which can constrain how quickly growth can compound.

Net debt to EBITDA near 6.0x and interest coverage of 2.2x reduce financial flexibility, limiting aggressive expansion relative to better-capitalized peers.

The current structure supports some scaling, but the evidence does not show the high reinvestment capacity typical of top-tier long-term compounders.

Constraints Limitations

Negative ROIC indicates incremental capital is currently destroying value, which structurally caps long-term growth quality versus peers with positive returns.

Leverage is elevated at nearly 6.0x net debt to EBITDA, so balance-sheet constraints may limit reinvestment and acquisition-led expansion.

Interest coverage of 2.2x leaves limited room for error, which can force capital discipline rather than sustained growth investment.

Missing five-year growth and margin history prevents confirmation of durable compounding, leaving the long-term growth profile less proven than peers.

Overall Score

LILA shows some scalability from relatively low capex intensity and working-capital efficiency, but negative ROIC and elevated leverage materially limit long-term compounding versus stronger peers.

Score Driver: Negative ROIC